MEDBOX | Toolbox Strategies & Action Plans

NEW

World Health Organization WHO (2921) C_WHO

An Action Framework and annexe to Immunization Agenda 2030 (Draft version) 27 January 2021

Tags: antibiotics, antibiotic use, resistance, Antimicrobial resistance, Strategy, Immunization,

Source: https://cdn.who.int/media/docs/default-s

Antibiotic Manufacturing Standard

AMR Industry Alliance (2022) CC

Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic. The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure that their antibiotics are made responsibly, helping to minimize the risk of AMR in the environment

Tags: AMR, Environment, pollution, Standards, ecotoxicity, drug manufacturing, Manufacturing, antibiotics,

Source: https://www.amrindustryalliance.org/wp-c

Antimicrobials supplied in community pharmacies in eastern Europe and central Asia in the early phases of the COVID-19 pandemic

World Health Organization WHO (2022) CC

During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community pharmacies during the COVID-19 pandemic in selected countries in eastern Europe and central Asia. Nine countries – Armenia, Georgia, Kazakhstan, Kyrgyzstan, North Macedonia, the Russian Federation, Serbia, Tajikistan and Uzbekistan – participated in this cross-sectional study

Tags: COVID-19, antimicrobial drugs, eastern europe, central asia, pharmacy,

Source: https://apps.who.int/iris/bitstream/hand

Priorités stratégiques de l’OMS pour lutter contre la résistance aux antimicrobiens : préserver les antimicrobiens pour aujourd’hui et pour demain

World Health Organization WHO (2022) C_WHO

Tags: antimicrobials, amr, Antimicrobial resistance, MDR-TB, strategy,

Source: https://apps.who.int/iris/bitstream/hand

WHO strategic priorities on antimicrobial resistance: preserving antimicrobials for today and tomorrow (Arabic Version)

World Health Organization WHO (2022) C_WHO

Tags: antimicrobials, amr, Antimicrobial resistance, MDR-TB, strategy,

Source: https://apps.who.int/iris/bitstream/hand

Policy Brief for the Legal Framework on Infection Prevention and Control

African Union; Africa CDC Centres for Disease Control and Prevention (2022) C1

The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at both the national level and in healthcare facilities. In developing this IPC Legal Framework, the Africa Centres for Disease Control and Prevention (Africa CDC) is furthering its mandates to harmonize disease control and prevention policies and promote the prevention and control of diseases by building capacity of public health institutions in Members States

Tags: Infection Prevention and Control (IPC), Antimicrobial resistance, implementing, framework, national level, Healthcare facilities,

Source: https://africacdc.org/download/policy-br

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Online Course

Open WHO; World Health Organization WHO (2022) C_WHO

The toolkit provides guidance on where to get started, including the structures and resources that should be put in place at the national and health-care facility level, through a stepwise approach in low-resource settings. As the ultimate goal of an AMS programme is sustainable behaviour change in physicians’ antibiotic prescribing practices, the toolkit also provides detailed guidance on how to plan, perform and assess AMS interventions – including feedback on antibiotic use over time. Finally, the toolkit provides an overview of the competencies an AMS team needs to guide health-care professionals in changing their antibiotic prescribing behaviours. Please note that this course is part of a training package, so please register for the complementary course WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities so that you can complete your learning journey

Tags: antimicrobial stewardship, guidance, Public health, Online Courses,

Source: https://openwho.org/courses/practical-to

WHO policy guidance on integrated antimicrobial stewardship activities. Online Course

Open WHO; World Health Organization WHO (2022) C_WHO

Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sector. It provides evidence-based and pragmatic recommendations to drive comprehensive and integrated AMS activities under the purview of a central national coordination unit, National AMR steering or coordinating committees or other equivalent national authorities. Please note that this course is part of a training package, so please register for the complementary course Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit so that you can complete your learning journey

Tags: antimicrobial stewardship, guidance, Public health, Online Courses,

Source: https://apps.who.int/iris/handle/10665/3

Strategic framework for collaboration on antimicrobial resistance

World Health Organization WHO (2022) C_WHO

Together for One Health. Building on the momentum of increased collaboration, the WHO, FAO, OIE and UNEP have developed a Strategic Framework for collaboration on antimicrobial resistance (AMR). This Framework reflects the joint work of the four organizations to advance a One Health response to AMR at the global, regional and country level. It broadly supports the implementation of the five pillars of the Global Action Plan on AMR, as well as strengthening global AMR governance

Tags: AMR, Antimicrobial resistance, framework, Strategy, OneHealth, governance, country level,

Source: https://apps.who.int/iris/rest/bitstream

Investigation of the Quality of the 12 Most-Used Antibiotics Available in Retail Private Pharmacies in Rwanda

Bizimana, T.; et al. (2022) CC

Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329. The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate deviations were found, suggesting that regular quality control of antibiotics is needed in Rwanda

Tags: Rwanda, antibiotics, pharmacies, medicines availability,

Source: https://mdpi-res.com/d_attachment/antibi

	Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance NEW World Health Organization WHO (2921) C_WHO View PDF(24) Download (27) Add to my MEDBOX An Action Framework and annexe to Immunization Agenda 2030 (Draft version) 27 January 2021 Tags: antibiotics, antibiotic use, resistance, Antimicrobial resistance, Strategy, Immunization, Source: https://cdn.who.int/media/docs/default-s
	Antibiotic Manufacturing Standard AMR Industry Alliance (2022) CC View PDF(2) Download (6) Add to my MEDBOX Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic. The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure that their antibiotics are made responsibly, helping to minimize the risk of AMR in the environment Tags: AMR, Environment, pollution, Standards, ecotoxicity, drug manufacturing, Manufacturing, antibiotics, Source: https://www.amrindustryalliance.org/wp-c
	Antimicrobials supplied in community pharmacies in eastern Europe and central Asia in the early phases of the COVID-19 pandemic World Health Organization WHO (2022) CC View PDF(2) Download (1) Add to my MEDBOX During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community pharmacies during the COVID-19 pandemic in selected countries in eastern Europe and central Asia. Nine countries – Armenia, Georgia, Kazakhstan, Kyrgyzstan, North Macedonia, the Russian Federation, Serbia, Tajikistan and Uzbekistan – participated in this cross-sectional study Tags: COVID-19, antimicrobial drugs, eastern europe, central asia, pharmacy, Source: https://apps.who.int/iris/bitstream/hand
	Priorités stratégiques de l’OMS pour lutter contre la résistance aux antimicrobiens : préserver les antimicrobiens pour aujourd’hui et pour demain World Health Organization WHO (2022) C_WHO View PDF(2) Download (3) Add to my MEDBOX Tags: antimicrobials, amr, Antimicrobial resistance, MDR-TB, strategy, Source: https://apps.who.int/iris/bitstream/hand
	WHO strategic priorities on antimicrobial resistance: preserving antimicrobials for today and tomorrow (Arabic Version) World Health Organization WHO (2022) C_WHO View PDF(4) Download (2) Add to my MEDBOX Tags: antimicrobials, amr, Antimicrobial resistance, MDR-TB, strategy, Source: https://apps.who.int/iris/bitstream/hand
	Policy Brief for the Legal Framework on Infection Prevention and Control African Union; Africa CDC Centres for Disease Control and Prevention (2022) C1 View PDF(12) Download (8) Add to my MEDBOX The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at both the national level and in healthcare facilities. In developing this IPC Legal Framework, the Africa Centres for Disease Control and Prevention (Africa CDC) is furthering its mandates to harmonize disease control and prevention policies and promote the prevention and control of diseases by building capacity of public health institutions in Members States Tags: Infection Prevention and Control (IPC), Antimicrobial resistance, implementing, framework, national level, Healthcare facilities, Source: https://africacdc.org/download/policy-br
	Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Online Course Open WHO; World Health Organization WHO (2022) C_WHO Open external link (43) Add to my MEDBOX The toolkit provides guidance on where to get started, including the structures and resources that should be put in place at the national and health-care facility level, through a stepwise approach in low-resource settings. As the ultimate goal of an AMS programme is sustainable behaviour change in physicians’ antibiotic prescribing practices, the toolkit also provides detailed guidance on how to plan, perform and assess AMS interventions – including feedback on antibiotic use over time. Finally, the toolkit provides an overview of the competencies an AMS team needs to guide health-care professionals in changing their antibiotic prescribing behaviours. Please note that this course is part of a training package, so please register for the complementary course WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities so that you can complete your learning journey Tags: antimicrobial stewardship, guidance, Public health, Online Courses, Source: https://openwho.org/courses/practical-to
	WHO policy guidance on integrated antimicrobial stewardship activities. Online Course Open WHO; World Health Organization WHO (2022) C_WHO Open external link (48) Add to my MEDBOX Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sector. It provides evidence-based and pragmatic recommendations to drive comprehensive and integrated AMS activities under the purview of a central national coordination unit, National AMR steering or coordinating committees or other equivalent national authorities. Please note that this course is part of a training package, so please register for the complementary course Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit so that you can complete your learning journey Tags: antimicrobial stewardship, guidance, Public health, Online Courses, Source: https://apps.who.int/iris/handle/10665/3
	Strategic framework for collaboration on antimicrobial resistance World Health Organization WHO (2022) C_WHO View PDF(12) Download (11) Add to my MEDBOX Together for One Health. Building on the momentum of increased collaboration, the WHO, FAO, OIE and UNEP have developed a Strategic Framework for collaboration on antimicrobial resistance (AMR). This Framework reflects the joint work of the four organizations to advance a One Health response to AMR at the global, regional and country level. It broadly supports the implementation of the five pillars of the Global Action Plan on AMR, as well as strengthening global AMR governance Tags: AMR, Antimicrobial resistance, framework, Strategy, OneHealth, governance, country level, Source: https://apps.who.int/iris/rest/bitstream
	Investigation of the Quality of the 12 Most-Used Antibiotics Available in Retail Private Pharmacies in Rwanda Bizimana, T.; et al. (2022) CC Open external link (52) Add to my MEDBOX Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329. The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate deviations were found, suggesting that regular quality control of antibiotics is needed in Rwanda Tags: Rwanda, antibiotics, pharmacies, medicines availability, Source: https://mdpi-res.com/d_attachment/antibi

About MEDBOX

MEDBOX Video Series